Suzhou Basecare Medical Past Earnings Performance
Past criteria checks 0/6
Suzhou Basecare Medical has been growing earnings at an average annual rate of 45.7%, while the Medical Equipment industry saw earnings growing at 14.7% annually. Revenues have been growing at an average rate of 31.4% per year.
Key information
45.7%
Earnings growth rate
58.1%
EPS growth rate
Medical Equipment Industry Growth | 13.7% |
Revenue growth rate | 31.4% |
Return on equity | -19.7% |
Net Margin | -101.2% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Suzhou Basecare Medical (HKG:2170) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway
Nov 18Lacklustre Performance Is Driving Suzhou Basecare Medical Corporation Limited's (HKG:2170) Low P/S
Sep 27Here's Why Shareholders May Want To Be Cautious With Increasing Suzhou Basecare Medical Corporation Limited's (HKG:2170) CEO Pay Packet
May 30Suzhou Basecare Medical Corporation Limited's (HKG:2170) Shares Leap 27% Yet They're Still Not Telling The Full Story
May 09Suzhou Basecare Medical Corporation Limited (HKG:2170) Screens Well But There Might Be A Catch
Mar 22Is There An Opportunity With Suzhou Basecare Medical Corporation Limited's (HKG:2170) 47% Undervaluation?
Aug 01Lacklustre Performance Is Driving Suzhou Basecare Medical Corporation Limited's (HKG:2170) 27% Price Drop
May 26Are Investors Undervaluing Suzhou Basecare Medical Corporation Limited (HKG:2170) By 48%?
Jul 20Revenue & Expenses Breakdown
How Suzhou Basecare Medical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 247 | -250 | 265 | 135 |
31 Mar 24 | 228 | -221 | 237 | 133 |
31 Dec 23 | 208 | -192 | 209 | 130 |
30 Sep 23 | 183 | -176 | 193 | 134 |
30 Jun 23 | 158 | -160 | 176 | 138 |
31 Mar 23 | 149 | -146 | 169 | 129 |
31 Dec 22 | 141 | -132 | 161 | 120 |
30 Sep 22 | 133 | -133 | 145 | 108 |
30 Jun 22 | 126 | -135 | 129 | 96 |
31 Mar 22 | 117 | -139 | 122 | 85 |
31 Dec 21 | 107 | -144 | 115 | 74 |
30 Sep 21 | 103 | -119 | 101 | 61 |
30 Jun 21 | 99 | -106 | 80 | 44 |
31 Mar 21 | 90 | -490 | 61 | 39 |
31 Dec 20 | 81 | -874 | 42 | 34 |
30 Sep 20 | 71 | -1,008 | 26 | 27 |
30 Jun 20 | 61 | -1,116 | 19 | 24 |
31 Mar 20 | 58 | -822 | 19 | 22 |
31 Dec 19 | 56 | -528 | 19 | 20 |
31 Dec 18 | 33 | -152 | 45 | 19 |
Quality Earnings: 2170 is currently unprofitable.
Growing Profit Margin: 2170 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 2170 is unprofitable, but has reduced losses over the past 5 years at a rate of 45.7% per year.
Accelerating Growth: Unable to compare 2170's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 2170 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-4.3%).
Return on Equity
High ROE: 2170 has a negative Return on Equity (-19.7%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/25 16:53 |
End of Day Share Price | 2024/12/24 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Suzhou Basecare Medical Corporation Limited is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Jiaying Fu | China International Capital Corporation Limited |
Shuo Song | Citic Securities Co., Ltd. |
Mujun Shen | Citic Securities Co., Ltd. |